Skip to main content

Kevin Moran

Acting Chief Financial Officer

Head of Investor Relations Head of Investor Relations Head of Investor Relations CFO COO Other

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Vanda Pharmaceuticals Inc. (VNDA) $559,935 $1,439,660
2025 AlTi Global, Inc. (ALTI) $450,000 $4,572,569
2024 Vanda Pharmaceuticals Inc. (VNDA) $541,000 $1,447,627
2024 AlTi Global, Inc. (ALTI) $400,000 $2,792,516
2023 Vanda Pharmaceuticals Inc. (VNDA) $477,000 $1,324,684
2022 Vanda Pharmaceuticals Inc. (VNDA) $426,120 $1,440,701
2022 AlTi Global, Inc. (ALTI) $375,000 $1,000,000
2021 Vanda Pharmaceuticals Inc. (VNDA) $402,000 $1,971,966
2020 Vanda Pharmaceuticals Inc. (VNDA) $324,693 $1,319,699

Executive changes

Earnings-call appearances